Resultats globals: 1 registres trobats en 0.01 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
11 p, 2.5 MB Nebulised heparin as a treatment for COVID-19 : Scientific rationale and a call for randomised evidence / Van Haren, Frank M. P. (Intensive Care Unit. Canberra Hospital) ; Page, Clive (Sackler Institute of Pulmonary Pharmacology. King's College London) ; Laffey, John (Galway University Hospital) ; Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Camprubí-Rimblas, Marta (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Nunes, Quentin (Institute of Systems. Molecular and Integrative Biology. University of Liverpool) ; Smith, Roger (St Vincent's Hospital (Sydney)) ; Shute, Janis (School of Pharmacy and Biomedical Science. University of Portsmouth) ; Carroll, Mary (National Infection Service. Public Health England) ; Tree, Julia (National Infection Service. Public Health England) ; Carroll, Miles (National Infection Service. Public Health England) ; Singh, Dave (Medicines Evaluation Unit. University of Manchester) ; Wilkinson, Tom (Department of Respiratory Medicine. University of Southampton) ; Dixon, Barry (St Vincent's Hospital (Sydney)) ; Universitat Autònoma de Barcelona. Departament de Medicina
Nebulised unfractionated heparin (UFH) has a strong scientific and biological rationale and warrants urgent investigation of its therapeutic potential, for COVID-19-induced acute respiratory distress syndrome (ARDS). [...]
2020 - 10.1186/s13054-020-03148-2
Critical Care, Vol. 24 Núm. 1 (22 2020) , p. 454  

Vegeu també: autors amb noms similars
1 Nunes, Q.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.